Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JEGY | ISIN: AU000000CUV3 | Ticker-Symbol: UR9
Tradegate
02.06.26 | 16:36
5,450 Euro
-3,74 % -0,212
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
CLINUVEL PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
CLINUVEL PHARMACEUTICALS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
5,3785,64202.06.
5,4445,57802.06.

Aktuelle News zur CLINUVEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL US Non-Deal Roadshow Presentation18
07.05.CLINUVEL PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - CUV23
27.04.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL update on Level II ADR upgrade, Nasdaq uplist29
26.04.CLINUVEL PHARMACEUTICALS LIMITED: FDA relaxes SCENESSE postmarketing requirement18
24.04.Clinuvel Pharmaceuticals Limited: CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study354EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its "totality of evidence" approachcentral photographic review and validated disease...
► Artikel lesen
23.04.CLINUVEL PHARMACEUTICALS LIMITED: Final EMA scientific advice for pivotal Phase III vitiligo4
CLINUVEL Aktie jetzt für 0€ handeln
17.04.CLINUVEL PHARMACEUTICALS LIMITED: Notification of cessation of securities - CUV6
15.04.Clinuvel Pharmaceuticals Limited: CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 202626
12.04.CLINUVEL PHARMACEUTICALS LIMITED: Section 708A Cleansing Statement20
12.04.CLINUVEL PHARMACEUTICALS LIMITED: Application for quotation of securities - CUV12
12.04.CLINUVEL PHARMACEUTICALS LIMITED: Change in substantial holding19
02.04.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL reports highlights from AAD 202634
27.03.Clinuvel Showcases AI-Powered Vitiligo Assessment Tool at AAD Conference31
27.03.Why 4DMedical, Clinuvel, Life360, and Silex shares are pushing higher today19
26.03.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL's global programs showcased at AAD4
26.03.Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy587Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH 26.03.2026 / 12:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The...
► Artikel lesen
19.03.CLINUVEL PHARMACEUTICALS LIMITED: Chair Letter to Shareholders40
04.03.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL Investor Webinar Half Year Results December 202519
04.03.Health Check: Cash is king in these troubled times, declares defiant Clinuvel40
27.02.Clinuvel Pharmaceuticals Limited H1 Profit Declines56
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1